Canton Hathaway LLC Boosts Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

Canton Hathaway LLC lifted its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 1.0% in the fourth quarter, Holdings Channel reports. The firm owned 9,961 shares of the financial services provider’s stock after buying an additional 100 shares during the period. Canton Hathaway LLC’s holdings in iShares Biotechnology ETF were worth $1,317,000 at the end of the most recent reporting period.

Other hedge funds have also recently modified their holdings of the company. BNP Paribas Financial Markets boosted its stake in iShares Biotechnology ETF by 29.3% during the third quarter. BNP Paribas Financial Markets now owns 2,380,229 shares of the financial services provider’s stock worth $346,561,000 after buying an additional 538,899 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund increased its stake in shares of iShares Biotechnology ETF by 32.9% in the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 663,000 shares of the financial services provider’s stock worth $96,533,000 after acquiring an additional 164,000 shares during the last quarter. Aprio Wealth Management LLC purchased a new position in shares of iShares Biotechnology ETF during the 4th quarter worth $18,476,000. DRW Securities LLC acquired a new position in shares of iShares Biotechnology ETF during the 3rd quarter valued at about $5,990,000. Finally, Erste Asset Management GmbH acquired a new position in shares of iShares Biotechnology ETF during the 3rd quarter valued at about $5,678,000. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

iShares Biotechnology ETF stock opened at $138.74 on Tuesday. The company has a 50-day moving average price of $135.64 and a 200 day moving average price of $140.77. iShares Biotechnology ETF has a 12-month low of $123.60 and a 12-month high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The business also recently announced a dividend, which was paid on Friday, December 20th. Shareholders of record on Tuesday, December 17th were paid a dividend of $0.0624 per share. The ex-dividend date of this dividend was Tuesday, December 17th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.